美股市場個股詳情
TEVA 梯瓦製藥
- 17.080
- +0.050+0.29%
收盤價 11/21 16:00 (美東)
- 17.213
- +0.133+0.78%
盤後 20:01 (美東)
193.52億總市值-20094市盈率TTM
17.170最高價16.901最低價834.72萬股成交量17.050今開17.030昨收1.42億成交額0.74%換手率虧損市盈率(靜)11.33億總股本19.31052周最高3.19市淨率192.38億流通值9.35052周最低--股息TTM11.26億流通股68.007歷史最高--股息率TTM1.58%振幅3.107歷史最低17.069平均價1股每手
關於梯瓦製藥公司
梯瓦製藥工業有限公司從事藥品的開發、生產和銷售。它通過以下地理部分運作:北美，歐洲和國際市場。
公司介紹
公司代碼TEVA
公司名稱梯瓦製藥
上市日期2012/05/30
成立日期1901
CEOMr. Richard D. Francis
所屬市場紐交所
員工數量37851
證券類型存託憑證
ADS轉換比例1.0 : 1.0
年結日12-31
公司地址124 Dvora HaNevi'a Street
城市特拉維夫
省份特拉維夫
國家以色列
郵編6944020
電話972-3-914-8213
董事高管
- 姓名
- 職務
- 年薪
- Richard D. Francis
- Director, President and Chief Executive Officer
- 2570.69萬
- David R. McAvoy
- Executive Vice President and Chief Legal Officer
- --
- Amir Weiss
- Senior Vice President and Chief Accounting Officer
- --
- Eric A Hughes
- Executive Vice President, Global R&D and Chief Medical Officer
- --
- Eli Kalif
- Executive Vice President and Chief Financial Officer
- 494.38萬
- Richard Daniell
- Executive Vice President, European Commercial
- 516.42萬
- Angus Grant
- Executive Vice President, Business Development
- --
- Mark Sabag
- Executive Vice President, International Markets Commercial
- 372.91萬
- Matthew Shields
- Executive Vice President, Global Operations
- --
- Christine Fox
- Executive Vice President, U.S. Commercial
- --
- Dr. Sol J. Barer,PhD
- Chairman of the Board
- 54.00萬
- Roberto A. Mignone
- Independent Director
- 34.00萬
- Dr. Perry D. Nisen
- Independent Director
- 32.79萬
- Janet S. Vergis
- Independent Director
- 32.55萬
- Amir Elstein
- Independent Director
- 34.00萬
- Gerald M. Lieberman
- Independent Director
- 35.50萬
- Chen Lichtenstein
- Independent Director
- --
- Rosemary A. Crane, M.B.A.
- Independent Director
- 33.00萬
- Professor Ronit Satchi-Fainaro
- Independent Director
- 31.52萬
- Dr. Tal Zaks, M.D.,PhD
- Independent Director
- 33.00萬
- Professor Varda Shalev
- Independent Director
- 17.67萬
- Vikki L. Conway
- Acting Head of Global Human Resources
- --
分析
目標價預測
暫無數據
熱議
美股
綜合熱度
股票代碼
最新價
升跌幅
暫無數據
